SGBCF
Shanghai Henlius Biotech Inc. - Ordinary Shares - Class H

1
Loading...
Loading...
Shanghai Henlius Biotech, Inc. engages in the production and sale of monoclonal antibody (mAb) drugs and the provision of related consultation and technical services, and the transfer of its own technology. It operates through the Mainland China and Overseas geographical segments. The company was founded by Wei Dong Jiang and Shi Gao Liu in 2010 and is headquartered in Shanghai, China.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3,515

Frequently Asked Questions

How many employess does Shanghai Henlius Biotech Inc. - Ordinary Shares - Class H has?

Latest SGBCF News

View
No SGBCF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.